ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 0985 • ACR Convergence 2023

    Assessing the Value of Comorbidity Clusters in Predicting Clinical Outcomes in Rheumatoid Arthritis: A Machine Learning Approach Using a Very Large US Registry

    Daniel Solomon1, Fredrik Johansson2, Hongshu Guan3, Leah Santacroce4, Lin Guo5, Wendi Malley5 and Heather Litman5, 1Brigham and Women's Hospital, Newton, MA, 2Chalmers University of Technology, Goteborg, Sweden, 3Brigham and Women's Hospital, Boston, MA, 4Brigham and Women's Hospital, Boston, MA, 5CorEvitas, LLC, Waltham, MA

    Background/Purpose: Comorbid conditions are very common in rheumatoid arthritis (RA) and several prior studies have derived comorbidity clusters using machine learning (ML). Clustering using ML…
  • Abstract Number: 1352 • ACR Convergence 2023

    Similar Delivery Outcomes in Pregnant Patients with and Without Takayasu Arteritis – A Nationwide Inpatient Database Study

    Yanint Raksadawan1, Aravind Polam1, Nattanicha Chaisrimaneepan2 and Sabahat Usmani1, 1Weiss Memorial Hospital, Chicago, IL, 2Texas Tech University Health Sciences, Lubbock, TX

    Background/Purpose: Takayasu's arteritis (TA) is a large vessel vasculitis which affects women of reproductive age. There is limited information about the effect of TA on…
  • Abstract Number: 1806 • ACR Convergence 2023

    The Prevalence of Cardiac Sarcoidosis – A Systemic Review and Meta-Analysis

    Daming Shao1, Jiyoung Seo1, Shaunak Mangeshkar1, Natalia Nazarenko1, Stepan Esagian1, Leonidas Palaiodimos1 and Damianos Kokkinidis2, 1Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY, 2Yale University School of Medicine, New Haven, CT

    Background/Purpose: Cardiac sarcoidosis (CS) results from granulomatous infiltrating of the myocardium and manifests as an extended clinical spectrum from silence to conduction disturbances, ventricular tachyarrhythmias,…
  • Abstract Number: 1979 • ACR Convergence 2023

    Weight Loss Induced by Anti-obesity Medications and All-cause Mortality Among Patients with Knee or Hip Osteoarthritis

    Jie Wei1, david Hunter2, Nancy Lane3, Jing Wu4, Chao Zeng5, Guanghua Lei5 and Yuqing Zhang6, 1Health Management Center, Xiangya Hospital Central South University, Changsha, China, 2Sydney Musculoskeletal Health, University of Sydney, St. Leonards, Australia, 3University of California, Hillsborough, CA, 4Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Changsha, China, 5Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China, 6Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA

    Background/Purpose: The current international guidelines recommend weight loss for pain relief and functional improvement in overweight or obese patients with knee or hip osteoarthritis; however,…
  • Abstract Number: 2281 • ACR Convergence 2023

    Epidemiology and Risk of Brain Abscess in Patients with Systemic Lupus Erythematosus in Taiwan: A Nationwide Population-based Study

    Ke-Hung Lin1, Tzu-Min Lin1 and Chi-Ching Chang2, 1Taipei Medical University Hospital, Taipei, Taiwan, 2Taipei Medical University, Taipei, Taiwan

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune systemic disorder with high morbidity and mortality. Although CNS infections account for only 0.53–2.25% of all infections…
  • Abstract Number: 2531 • ACR Convergence 2023

    Proton Pump Inhibitor Use Is Associated with Impaired Bone Mineral Density but Not Bone Microarchitecture in Patients with Inflammatory Rheumatic and Musculoskeletal Diseases Taking Glucocorticoids

    Andriko Palmowski1, Gabriela Schmajuk2, Jinoos Yazdany3, Patti Katz4, Jing Li5, Rachael Stovall5, Emma Kersey5, Sabrina Mai Nielsen6, Robin Christensen7, Henning Bliddal8, Zhivana Boyadzhieva9, Udo Schneider9, Tobias Alexander10, Burkhard Muche11, Sandra Hermann11, Edgar Wiebe11 and Frank Buttgereit11, 1Charité - Universitätsmedizin Berlin, Berlin, Germany, 2UCSF / SFVA, San Francisco, CA, 3University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA, 4University of California San Francisco, San Rafael, CA, 5University of California San Francisco, San Francisco, CA, 6The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, 7Musculoskeletal Statistics Unit, The Parker Institute, Copenhagen, Denmark, 8The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark, 9Charité Universitatsmedizine - Berlin, Berlin, Germany, 10Charité Universiätsmedizin Berlin, Dept. Rheumatology, Berlin, Germany, 11Charité Universitätsmedizin, Dept. Rheumatology, Berlin, Germany

    Background/Purpose: Patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs) are at increased risk of osteoporosis and fragility fractures. For this population, whether proton pump inhibitor…
  • Abstract Number: 0147 • ACR Convergence 2023

    Leukotriene Inhibitors Effect on Post-Traumatic Osteoarthritis: A Real-World Evidence Comparative Effectiveness Study

    S. Reza Jafarzadeh1, Matthew Baker2, Christine E. Peloquin3, William H. Robinson4 and David Felson3, 1Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 2Stanford University, Menlo Park, CA, 3Boston University, Boston, MA, 4Stanford University, Palo Alto, CA

    Background/Purpose: Joint injuries frequently lead to post-traumatic osteoarthritis (OA), a disabling condition often affecting young adults, impacting their quality of life and creating substantial economic…
  • Abstract Number: 0483 • ACR Convergence 2023

    The Influence of “Fibromyalgia-ness” on Treatment Response Amongst Patients with Psoriatic Arthritis (PsA). Results from the British Society for Rheumatology Psoriatic Arthritis Register (BSR‐PsA)

    Gary Macfarlane1, Ovidiu Rotariu2, Stephanie Lembke2, Flavia Sunzini3, Gareth T. Jones1 and Neil Basu3, 1Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 2University of Aberdeen, Aberdeen, United Kingdom, 3University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: Co-morbid fibromyalgia has been shown to be an important influence on non-response in patients with some inflammatory arthritides. Around 1 in 5 patients with…
  • Abstract Number: 0742 • ACR Convergence 2023

    Risk of Incident Gout Associated with Initiation of Sodium-glucose cotransporter-2 Inhibitors versus Other Second-line Agents Among Metformin Users with Type 2 Diabetes

    Natalie McCormick1, Chio Yokose2, Na Lu3 and Hyon K. Choi4, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Waltham, MA, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Massachusetts General Hospital and Harvard Medical School, Lexington, MA

    Background/Purpose: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are a revolutionary second-line treatment for type 2 diabetes associated with lower risk of cardiovascular and all-cause mortality, heart failure,…
  • Abstract Number: 0986 • ACR Convergence 2023

    Medication Use Patterns and Factors Associated with Abnormal Pregnancy Outcomes in Patients with Rheumatoid Arthritis in Korea

    Yeo-Jin Song1, Soo-Kyung Cho1, Yu-Seon Jung2, Jihyun Keum3, Sun-Young Jung2, Dae Hyun Yoo4 and Yoon-Kyoung Sung1, 1Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 2College of Pharmacy, Chung-Ang University, Seoul, South Korea, 3Department of Obstetrics and Gynecology, College of Medicine, Hanyang University, Seoul, South Korea, 4Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea

    Background/Purpose: As female patients constitute a significant proportion of rheumatoid arthritis (RA) cases, pregnancy management is crucial for women with RA. This study aimed to…
  • Abstract Number: 1386 • ACR Convergence 2023

    Opioid Prescription Rates in Patients with Ankylosing Spondylitis in the UK Between 2001-2020: An Electronic Health Records (EHR) Analysis

    Huseyin Berk Degirmenci1, Christine E. Peloquin2, Sara Lodi2, Pedro Machado3, S. Reza Jafarzadeh4, Tuhina Neogi5, Lianne Gensler6, Maureen Dubreuil7 and Jean Liew2, 1St. Elizabeth's Medical Center, Boston, MA, 2Boston University, Boston, MA, 3Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK. Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS trust, London, UK., London, United Kingdom, 4Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 5Boston University School of Medicine, Boston, MA, 6University of California San Francisco, Department of Medicine, Division of Rheumatology, San Francisco, CA, 7Department of Rheumatology, Boston University School of Medicine, Milton, MA

    Background/Purpose: Although current axial spondyloarthritis (axSpA) management guidelines do not address opioid use for chronic pain, available data show that opioid use is common among…
  • Abstract Number: 1808 • ACR Convergence 2023

    Tobacco Smoking Reduces the Incidence and Delays the Progression of Knee Osteoarthritis: 10-year Retrospective Cohort Study Based on Korea National Health Insurance Service-Health Screening Database

    Junyong Park1, Minkook Son2, Sang Yeob Lee1, Wontae Chung1 and SungWon Lee1, 1Dong-A University Hospital, Busan, South Korea, 2Dong-A University, Busan, South Korea

    Background/Purpose: There are conflicting results about relationship between smoking and incidence of knee osteoarthritis (OA). The effect of smoking to preexisting knee OA has also…
  • Abstract Number: 2011 • ACR Convergence 2023

    Predicting Fractures in Patients with Isolated Lumbar Spine Osteoporosis Compared to Those with Isolated Hip Osteoporosis

    Nicholas Rossi1, Aamir Saeed2, Aqib Khan3, Hamzah Amin2, Ummaz Nadeem2, Zain Sultan3 and Marwan Bukhari2, 1University Hospitals of Morecambe Bay Foundation Trust, Worksop, United Kingdom, 2Lancaster University, Lancaster, United Kingdom, 3University Hospitals of Morecambe Bay Foundation Trust, Lancaster, United Kingdom

    Background/Purpose: Osteoporosis (OP) presents with fragility fractures, which can cause significant disability and cost to health services globally. There has been extensive research looking at…
  • Abstract Number: 2300 • ACR Convergence 2023

    Outcomes of COVID-19 Before and During the Omicron Variant Period in Patients with Systemic Lupus Erythematosus: A Global Multicenter Cohort Study Using the TriNetX Network

    Wen-Nan Huang1 and Hsin-Hua Chen2, 1Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Veterans General Hospital, College of Medicine National Chung Hsing University, Department of Business Administration, Ling-Tung University, Taichung, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, 2Taichung Veterans General Hospital, Taichung, Taiwan

    Background/Purpose: The global dominance of the SARS-CoV-2 Omicron variant ensued shortly after its initial identification in South Africa on November 24, 2021. The outcomes of…
  • Abstract Number: 2532 • ACR Convergence 2023

    Prevalence and Disease-Specific Factors Associated with Osteoporosis in Systemic Sclerosis: A Cross-Sectional Analysis of Two Large European Cohorts

    Charles MIDOL1, Edgar Wiebe2, Elise Siegert3, Dörte Huscher4, Helene Behal5, David Launay6, Eric Hachulla7, Eric Matteson8, Vincent Sobanski9 and Frank Buttgereit2, 1Lille University Hospital, Besançon, France, 2Charité Universitätsmedizin, Dept. Rheumatology, Berlin, Germany, 3Department of Rheumatology, Charité University Hospital, Charité Platz 1, D-10117, Berlin, Germany, 4Institute of Biometry and Clinical Epidemiology and Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Germany, 5Univ. Lille, CHU Lille, Biostatistics Department, Lille, France, 6Univ. Lille, Inserm, CHU Lille, Service de Médecine Interne, Lille, France, 7CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Lille, France, 8Mayo Clinic College of Medicine and Science, Rochester, MN, USA, Rochester, MN, 9Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France

    Background/Purpose: Patients with systemic sclerosis (SSc) are at increased risk for osteoporosis (OP) and associated fragility fractures. However, the risks factors and mechanisms driving bone…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 46
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology